Solid Sales Growth in Hearing Instruments
Achieved 5.9% sales growth in local currencies, driven by share gains in hearing instruments and cochlear implants. Hearing instruments grew by 7% despite late cycle ASP pressure.
Successful Product Launches
Positive reception and strong momentum for Infinio and Sphere product launches, particularly in addressing hearing in noisy environments. Initial constraints on shipments resolved by end of September.
Cochlear Implants Growth
Cochlear implants segment showed 12.5% growth, with system sales up by 18.2%, attributed to remote functionality and lead generation from retail stores.
Improvement in Gross Profit Margin
Gross profit margin improved by 50 basis points in local currency, driven by higher volume in hearing instruments and lower component costs.